Li Sheng
Directeur/Membre du Conseil chez HeMo (China) Bioengineering Co., Ltd.
Profil
Li Sheng is currently a Non-Executive Director and Director at HeMo (China) Bioengineering Co., Ltd.
and HeMo (China) Bioengineering Ltd.
respectively.
Previously, he worked as a Non-Executive Non-Independent Director at Biosensors International Group Ltd.
from 2011 to 2012, and as an Investment Director-Health Industry at Hony Capital Ltd.
from 2006 to 2016.
He also served as a Non-Executive Director at Everest Green Ltd.
Mr. Sheng holds an MBA from Tsinghua University and an undergraduate degree from China Pharmaceutical University.
Postes actifs de Li Sheng
| Sociétés | Poste | Début |
|---|---|---|
HeMo (China) Bioengineering Co., Ltd.
 HeMo (China) Bioengineering Co., Ltd. Information Technology ServicesTechnology Services HeMo Bioengineering Ltd. operates as a medical device company. Its portfolio of neuro-interventional medical devices covers all of the ischemic stroke, hemorrhagic stroke and neuro access fields. The company was founded in June 21, 2017 and is headquartered in Weihai, China. | Directeur/Membre du Conseil | 25/08/2020 |
| HeMo (China) Bioengineering Ltd. | Directeur/Membre du Conseil | 01/04/2020 |
Anciens postes connus de Li Sheng
| Sociétés | Poste | Fin |
|---|---|---|
Hony Capital Ltd.
 Hony Capital Ltd. Investment ManagersFinance Hony Capital Ltd. operates as a private equity firm and provides investment advice. It focuses on investments in consumer sectors, advanced manufacturing and healthcare services. The company was founded by Ling Huan Zhao on March 15, 2004 and is headquartered in Hong Kong. | Corporate Officer/Principal | 01/03/2016 |
| BIOSENSORS INTERNATIONAL GROUP LTD | Directeur/Membre du Conseil | 26/07/2012 |
Everest Green Ltd.
 Everest Green Ltd. BiotechnologyHealth Technology Pacific Biopharmaceutical Ltd. was an investment holding company, which engaged in the research, development, manufacture, and sale of plama-derived biopharmaceutical products. It provided treatment for people suffering from genetic diseases, bleeding disorders, immunodeficiency, pulmonary disorders, neurological disorders, traumatic of hemorrhagic shocks, severe burns, liver cirrhosis, and infectious diseases. Its products included Albumin, Immunoglobulins, and Coagulation factors. The company was founded by Fu Shao Lan on March 20, 2015 and was headquartered in Harbin, China. | Directeur/Membre du Conseil | - |
Formation de Li Sheng
| Tsinghua University | Masters Business Admin |
| China Pharmaceutical University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Biosensors International Group Ltd.
 Biosensors International Group Ltd. Medical SpecialtiesHealth Technology Biosensors International Group Ltd. develops, manufactures, and markets medical devices for interventional cardiology and critical care procedures. It operates through the following segments: Interventional Cardiology, Critical Care, Cardiac Diagnostic, and Licensing Revenue. The company was founded in 1990 by Yoh Chie Lu and is headquartered in Singapore. | Health Technology |
Everest Green Ltd.
Everest Green Ltd. BiotechnologyHealth Technology Pacific Biopharmaceutical Ltd. was an investment holding company, which engaged in the research, development, manufacture, and sale of plama-derived biopharmaceutical products. It provided treatment for people suffering from genetic diseases, bleeding disorders, immunodeficiency, pulmonary disorders, neurological disorders, traumatic of hemorrhagic shocks, severe burns, liver cirrhosis, and infectious diseases. Its products included Albumin, Immunoglobulins, and Coagulation factors. The company was founded by Fu Shao Lan on March 20, 2015 and was headquartered in Harbin, China. | Health Technology |
HeMo (China) Bioengineering Co., Ltd.
HeMo (China) Bioengineering Co., Ltd. Information Technology ServicesTechnology Services HeMo Bioengineering Ltd. operates as a medical device company. Its portfolio of neuro-interventional medical devices covers all of the ischemic stroke, hemorrhagic stroke and neuro access fields. The company was founded in June 21, 2017 and is headquartered in Weihai, China. | Technology Services |
| HeMo (China) Bioengineering Ltd. | |
Hony Capital Ltd.
Hony Capital Ltd. Investment ManagersFinance Hony Capital Ltd. operates as a private equity firm and provides investment advice. It focuses on investments in consumer sectors, advanced manufacturing and healthcare services. The company was founded by Ling Huan Zhao on March 15, 2004 and is headquartered in Hong Kong. | Finance |
